WHO ICTRP trial
Percutaneous intra-articular injections of ropivacaine, and tranexamic acid…
ChiCTR2200059659 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200059659 |
|---|---|
| Public title | Percutaneous intra-articular injections of ropivacaine, and tranexamic acid after total knee arthroplasty as a component of enhanced recovery after surgery: a randomized control trial |
| Scientific title | Percutaneous intra-articular injections of ropivacaine, and tranexamic after total knee arthroplasty as a component of enhanced recovery after surgery: a randomized control trial |
| Primary sponsor | The First Affiliated Hospital of Bengbu Medical College |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Total knee arthroplasty |
| Interventions | Intervention group:Intraarticular injection of tranexamic acid and ropivacaine after total knee arthroplasty ;Control group:None |
| Registration date | May 5, 2022 |
| Target size | Intervention group:40;Control group:40 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: